Trivant Custom Portfolio Group, LLC Abbott Laboratories Transaction History
Trivant Custom Portfolio Group, LLC
- $173 Billion
- Q3 2024
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 14,773 shares of ABT stock, worth $1.69 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
14,773
Previous 24,142
38.81%
Holding current value
$1.69 Million
Previous $2.51 Billion
32.86%
% of portfolio
0.97%
Previous 1.54%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...